| Paul K Herickhoff, MD | |
|
1850 E Park Ave Ste 112, State College, PA 16803-6706 | |
| (814) 865-3566 | |
| (814) 863-7803 |
| Full Name | Paul K Herickhoff |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 17 Years |
| Location | 1850 E Park Ave Ste 112, State College, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417153768 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | MD460062 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Advantage Home Health Services, Llc | Altoona, PA | Home health agency |
| Mount Nittany Medical Center | State college, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Milton S Hershey Medical Center Physicians Group | 3870405483 | 1400 |
| Keystone Rehabilitation Systems Inc | 7012826753 | 505 |
News Archive
The nanopharmaceutical drug CRLX101 is showing promise as a potential new treatment for cancers that develop resistance to antiangiogenic drugs and radiation therapy, according to clinical trial results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19 - 23.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has entered into settlement and license agreements with Wyeth, now part of Pfizer, relating to Venlafaxine Hydrochloride (HCl) Extended Release (ER) Capsules, 37.5 mg, 75 mg and 150 mg, the generic version of Wyeth's Effexor XR® Capsules, a treatment for major depressive disorder.
Western Australia has been debating euthanasia for a while and in a new development, Health Minister and Deputy Premier Kim Hames has admitted that as a GP he administered the painkiller morphine to hasten a cancer patient's death. He said in his statement that what he had done was legal and not euthanasia – which he opposed. His reasoning was that the pain relieving medication was intended to ease a patient's suffering rather than end their life.
University of Adelaide researchers have uncovered the role played by a gene which suppresses the development of cancer. The findings, published in the journal PLOS ONE, open new opportunities for scientists to find treatments for cancer.
ENLASO Corporation, a leading provider of medical and life sciences translation and localization solutions, today announced that it has launched a new social networking forum dedicated to helping improve the quality in medical and life sciences translations.
› Verified 8 days ago
| Entity Name | The Milton S Hershey Medical Center Physicians Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710951744 PECOS PAC ID: 3870405483 Enrollment ID: O20040225000741 |
News Archive
The nanopharmaceutical drug CRLX101 is showing promise as a potential new treatment for cancers that develop resistance to antiangiogenic drugs and radiation therapy, according to clinical trial results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19 - 23.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has entered into settlement and license agreements with Wyeth, now part of Pfizer, relating to Venlafaxine Hydrochloride (HCl) Extended Release (ER) Capsules, 37.5 mg, 75 mg and 150 mg, the generic version of Wyeth's Effexor XR® Capsules, a treatment for major depressive disorder.
Western Australia has been debating euthanasia for a while and in a new development, Health Minister and Deputy Premier Kim Hames has admitted that as a GP he administered the painkiller morphine to hasten a cancer patient's death. He said in his statement that what he had done was legal and not euthanasia – which he opposed. His reasoning was that the pain relieving medication was intended to ease a patient's suffering rather than end their life.
University of Adelaide researchers have uncovered the role played by a gene which suppresses the development of cancer. The findings, published in the journal PLOS ONE, open new opportunities for scientists to find treatments for cancer.
ENLASO Corporation, a leading provider of medical and life sciences translation and localization solutions, today announced that it has launched a new social networking forum dedicated to helping improve the quality in medical and life sciences translations.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Paul K Herickhoff, MD Po Box 858, Mc A410, Hershey, PA 17033-0858 Ph: (800) 243-1455 | Paul K Herickhoff, MD 1850 E Park Ave Ste 112, State College, PA 16803-6706 Ph: (814) 865-3566 |
News Archive
The nanopharmaceutical drug CRLX101 is showing promise as a potential new treatment for cancers that develop resistance to antiangiogenic drugs and radiation therapy, according to clinical trial results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19 - 23.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has entered into settlement and license agreements with Wyeth, now part of Pfizer, relating to Venlafaxine Hydrochloride (HCl) Extended Release (ER) Capsules, 37.5 mg, 75 mg and 150 mg, the generic version of Wyeth's Effexor XR® Capsules, a treatment for major depressive disorder.
Western Australia has been debating euthanasia for a while and in a new development, Health Minister and Deputy Premier Kim Hames has admitted that as a GP he administered the painkiller morphine to hasten a cancer patient's death. He said in his statement that what he had done was legal and not euthanasia – which he opposed. His reasoning was that the pain relieving medication was intended to ease a patient's suffering rather than end their life.
University of Adelaide researchers have uncovered the role played by a gene which suppresses the development of cancer. The findings, published in the journal PLOS ONE, open new opportunities for scientists to find treatments for cancer.
ENLASO Corporation, a leading provider of medical and life sciences translation and localization solutions, today announced that it has launched a new social networking forum dedicated to helping improve the quality in medical and life sciences translations.
› Verified 8 days ago
Dr. Dov A Bader, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1850 E Park Ave, Suite 112, State College, PA 16803 Phone: 814-865-3566 Fax: 814-863-7803 | |
Dr. Edwin J Rogusky, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 101 Regent Ct, State College, PA 16801 Phone: 814-231-2101 Fax: 814-231-8569 | |
Thomas J Ellis, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 101 Regent Ct, State College, PA 16801 Phone: 814-231-2101 Fax: 814-231-8569 | |
Dr. Christopher J. Lincoski, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 101 Regent Ct, State College, PA 16801 Phone: 814-231-2101 Fax: 814-231-8569 | |
James S Martin, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1700 Old Gatesburg Rd Ste 200, State College, PA 16803 Phone: 814-237-4321 Fax: 814-235-0484 | |
Kenneth L Cherry, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 476 Rolling Drive Drive, Suite 200, State College, PA 16801 Phone: 814-231-2101 Fax: 814-231-8569 |